Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Proof is in the spending: CEO-to-CEO Challenge yields results in diversifying supply chains
Editor’s note: The following story was sponsored by KC Rising, a regional initiative to help Kansas City grow faster and more intentionally, as part of a campaign to promote its CEO-to-CEO Challenge on supplier diversity. When she started researching the institutional knowledge at MMC Corp. about working with diverse suppliers, national purchasing director Kelli Fraas found the process was…
Her new role is reenvisioning one of KC’s most iconic events for entrepreneurs; how Callie England is shaking up GEW
Callie England misses the life of an entrepreneur, she shared, but her new role with the UMKC Innovation Center — and GEWKC — allows her to stay in the game without being on the field. As of January, the veteran Kansas City startup founder is responsible for managing the branding and marketing initiatives of the…
Sand volleyball tourney for early-career professions works to ‘Spike the Stigma’ on mental health
Joining the workforce is no walk on the beach, said Mark Potts, but give him and his teammates a few hours in the sun and sand on a Saturday afternoon and it could be. “Nobody is on their journey alone,” said Potts, president of the Go Further Foundation, explaining the organization’s purpose and its goal…
Sailes closes $5.1M investment round led by STL firm, with KCRise Fund, Wichita VC
The foundation for Sailes has always been solving difficult problems for sales teams, said Nick Smith; the success of a Series A funding round for the startup will power new tools toward that goal. “Everyone is on this AI hype train, and we’ve been for AI for a while. But it’s not just about using…